Cargando…

Epstein–Barr virus seroprevalence and viral load at disease onset in children with inflammatory bowel disease

BACKGROUND AND AIM: Patients with inflammatory bowel disease (IBD) are at increased risk for life‐threatening complications of Epstein–Barr virus (EBV), including lymphoproliferative diseases. These complications are likely related to inherent immune dysfunction and immunomodulating therapies often...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kornitzer, Gaël, Rosenstein, Michelle, Turcotte, Marie‐Catherine, Godin, David, Groleau, Véronique, Renaud, Christian, Touzot, Fabien, Jantchou, Prevost, Ovetchkine, Philippe, Deslandres, Colette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446410/ https://www.ncbi.nlm.nih.gov/pubmed/36091316 http://dx.doi.org/10.1002/jgh3.12799

Ejemplares similares

Phenotype and outcomes of very early onset and early onset inflammatory bowel diseases in a Montreal pediatric cohort
por: Chapuy, Laurence, et al.
Publicado: (2023)

Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients
por: Samarani, Suzanne, et al.
Publicado: (2020)

1601. Effect of Preemptive Rituximab Therapy on Epstein–Barr Reactivation in Allogenic Hematopoietic Stem Cell Pediatric Transplants
por: Catho, Gaud, et al.
Publicado: (2018)

A203 EARLY PROACTIVE DRUG MONITORING STRATEGY OF INFLIXIMAB AS MONOTHERAPY FOR INFLAMMATORY BOWEL DISEASE IN PAEDIATRIC PATIENTS IS ASSOCIATED WITH GOOD SUSTAINED CLINICAL REMISSION
por: Girard, C, et al.
Publicado: (2023)

Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease
por: Labrosse, Roxane, et al.
Publicado: (2017)

A Large-Scale Seroprevalence of Epstein-Barr Virus in Taiwan
por: Chen, Chao-Yu, et al.
Publicado: (2015)

Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
por: Zhang, Hui, et al.
Publicado: (2022)

A253 IMPACT OF THE COVID-19 PANDEMIC LOCKDOWN ON PHYSICAL ACTIVITY LEVELS IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE IN QUEBEC
por: Bouthot, J, et al.
Publicado: (2022)

Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study
por: Sassine, Samuel, et al.
Publicado: (2021)

Seroprevalence of Epstein–Barr virus among children and adults in Tehran, Iran
por: Sharifipour, S., et al.
Publicado: (2020)

Activating Killer-cell Immunoglobulin-like Receptor genes confer risk for Crohn’s disease in children and adults of the Western European descent: Findings based on case-control studies
por: Samarani, Suzanne, et al.
Publicado: (2019)

Appendectomy and risk for inflammatory bowel disease: effect of age and time post appendectomy – a cohort study
por: Fantodji, Canisius, et al.
Publicado: (2022)

Epstein-Barr Virus and Neurological Diseases
por: Zhang, Nan, et al.
Publicado: (2022)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Clinical features of Epstein–Barr virus in the intestinal mucosa and blood of patients with inflammatory bowel disease
por: Zhou, Jin-Qiu, et al.
Publicado: (2020)

Epstein-Barr Virus Antibodies in Kawasaki Disease
por: Lee, Soon-Ju, et al.
Publicado: (2006)

Epstein-Barr Virus (Infectious Disease and Therapy)
por: Pagano, Joseph
Publicado: (2006)

Epstein-Barr Virus in Systemic Autoimmune Diseases
por: Draborg, Anette Holck, et al.
Publicado: (2013)

Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017)

Epstein-Barr Virus and Systemic Autoimmune Diseases
por: Houen, Gunnar, et al.
Publicado: (2021)

Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010
por: Dowd, Jennifer Beam, et al.
Publicado: (2013)

Seroprevalence of Epstein–Barr virus infection in children during the COVID-19 pandemic in Zhejiang, China
por: Cai, Fengqing, et al.
Publicado: (2023)

Chronic active Epstein-Barr virus infection involving gastrointestinal tract mimicking inflammatory bowel disease
por: Xu, Weijia, et al.
Publicado: (2020)

Epstein–Barr Virus Prevalence at Diagnosis and Seroconversion during Follow-Up in Pediatric Inflammatory Bowel Disease
por: Bachmann, Jennifer, et al.
Publicado: (2021)

Epstein–Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease
por: Andari, Sirine, et al.
Publicado: (2021)

Epstein–Barr Virus and Human Cytomegalovirus Infection in Intestinal Mucosa of Chinese Patients With Inflammatory Bowel Disease
por: Wang, Wei, et al.
Publicado: (2022)

Epstein–Barr Virus, the Immune System, and Associated Diseases
por: Chen, Mei-Ru
Publicado: (2011)

Possible roles of Epstein-Barr virus in Castleman disease
por: Chen, Chih-Hao, et al.
Publicado: (2009)

Epstein-Barr Virus Sequence Variation—Biology and Disease
por: Tzellos, Stelios, et al.
Publicado: (2012)

Epstein-Barr Virus Association with Peptic Ulcer Disease
por: Cárdenas-Mondragón, María G., et al.
Publicado: (2015)

Epstein–Barr Virus: Diseases Linked to Infection and Transformation
por: Jha, Hem C., et al.
Publicado: (2016)

GATA2 Deficiency and Epstein–Barr Virus Disease
por: Cohen, Jeffrey I.
Publicado: (2017)

Epstein-Barr virus: the molecular virology and the associated diseases
por: Murata, Takayuki
Publicado: (2023)

Virological Markers in Epstein–Barr Virus-Associated Diseases
por: Lupo, Julien, et al.
Publicado: (2023)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Positive correlation between latent Epstein-Barr virus infection and severity of illness in inflammatory bowel disease patients
por: Wei, Hong-Tao, et al.
Publicado: (2023)

A81 TRANSITION PRACTICES FROM PEDIATRIC TO ADULT CARE OF CHILDREN LIVING WITH CROHN’S DISEASE IN QUEBEC
por: Gong, R, et al.
Publicado: (2022)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Epstein-Barr Virus as a Trigger of Autoimmune Liver Diseases
por: Rigopoulou, Eirini I., et al.
Publicado: (2012)

Host genetics of Epstein–Barr virus infection, latency and disease
por: Houldcroft, Charlotte J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2ko18jbjk6d9gjphlh1bdg314j